Skip to main content

Brookmont Capital Management

Position in JNJ — Johnson & Johnson

CIK 1512978 Dallas, TX

Position in JNJ

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$3,618,818
+$1,105,731 QoQ
Shares Held
14,249
+38.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#1,859
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Brookmont Capital Management holds $13,411,938 across 3 Drug Manufacturers - General names. JNJ ranks #3 (27.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JNJ
Johnson & Johnson
This page
14,249 $3,618,818

All Filings in JNJ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,618,818 14,249
2026-03-31 $2,513,087 10,281
2025-12-31 $2,079,640 10,049
2025-09-30 $1,875,523 10,115
2025-06-30 $1,612,123 10,554
2025-03-31 $1,811,802 10,925
2024-12-31 $1,671,373 11,557
2024-09-30 $2,364,617 14,591
2024-06-30 $2,172,814 14,866
2024-03-31 $2,380,284 15,047
2023-12-31 $2,327,902 14,852
2023-09-30 $2,303,231 14,788
2023-06-30 $2,461,778 14,873
2023-03-31 $2,306,400 14,880
2022-12-31 $2,623,252 14,850
2022-09-30 $2,506,269 15,342
2022-06-30 $2,556,676 14,403
2022-03-31 $2,640,195 14,897
2021-12-31 $2,518,321 14,721
2021-09-30 $2,475,956 15,331
2021-06-30 $2,509,319 15,232
2021-03-31 $2,505,022 15,242
2020-12-31 $2,438,445 15,494
2020-09-30 $2,400,838 16,126
2020-06-30 $2,227,438 15,839
2020-03-31 $2,608,700 19,894